About

Ulf Krueger’s deep knowledge in respiratory drug delivery combined with his strong management skills and innovative entrepreneurial vision are the foundation of Pulmotree. His comprehensive experience involves key areas across the nebuliser industry lifecycle, from R&D, through corporate strategy to successful commercialisation. In his former position as Director – Fox Nebuliser Programs at Vectura, he was responsible for the entire sector of mesh nebulisers. Previously, he held various positions in the R&D department of PARI.

He is a graduate biomedical engineer and a certified senior project manager (IPMA® Level B) and is a member of The Aerosol Society, the European Respiratory Society and the International Society for Aerosols in Medicine.

Contributions

EXPERT VIEW

EXPLORING THE POTENTIAL OF NEBULISED BIOLOGICS

Carolina Dantas and Ulf Krueger consider the challenges when it comes to the successful delivery of inhaled biological drugs.

More contributions

EXPERT VIEW

THE IMPORTANCE OF THE BREATHING MANOEUVRE IN NEBULISED THERAPIES

Carolina Dantas and Ulf Krueger highlight the importance of the breathing manoeuvre in nebulised therapies – and describe a small study designed to test the effectiveness of patient feedback technology when it comes to guiding the inhalation manoeuvre.

EXPERT VIEW

THE POTENTIAL OF CONNECTIVITY AND MONITORING IN MESH NEBULISERS

Carolina Dantas and Ulf Krueger review the current connectivity and remote monitoring capabilities in mesh nebulisers – and their potential to impact patients’ healthcare journeys and the clinical development of inhaled therapies.